Another sampling of new technologies in various stages of development at recently founded medical technology startups:
Surgical drain and other technologies
Novel wound healing and drug delivery based on unique hydrogel
Nitric oxide coatings for blood-contacting medical devices
Bioresorbable implants for a range of surgical applications
Device to block transmission of pathogens via intravenous catheters
Self-expanding stent for femoral and popliteal [...]
Technologies for ablation and other energy-based treatments in medical/surgical markets are currently dominated by electrosurgical-type therapies, but a growing array of other modalities are creating new applications or penetrating existing ones.
At right is shown the forecast, by modality type, of ablation and other energy-based therapies through 2017. The most significant growth is expected to [...]
The formation of new companies in any industry can be a true litmus of the overall health of the industry and an indicator of the direction the industry is taking through the relative balance of companies with different areas of focus. We present in a bar graph the number of medtech startup companies categorized by [...]
Below is the coverage in the April 2008 issue of MedMarkets.
Ablation: An Energized Market
Demand for Hip and Knee Implants Expected to Increase
MedMarket Outlook: Beyond Technology Innovation: Current and Future Market Forces and Trends
Early Stage Companies: Evalve, ES Vascular, Cardiorobotics, TriVascular
Early Stage Company Financings: Alure Medical, Arbel Medical, Breathe Technologies, CoAxia, IDev Technologies, IlluminOss [...]
We have just updated our “High Growth Medical Technologies” white paper, as we expect to continually do in the immediate future, since the areas with growth keep changing, and new areas keep appearing.
As all white papers should be, it’s free. Here’s the link so you can download it.
bookmark to
Compiling from our secret blend of information sources, we came across startups with the following new technologies in development:
Stents (tantalum, zirconium, niobium, and/or tungsten)
Mesh devices used to facilitate laparoscopic procedures.
Undisclosed technology
Minimally invasive removal of varicose veins and removal of the greater saphenous vein
Medtech platform company focused on cardiovascular and surgical applications
Medical device company launched by [...]
From the December 2007 edition of MedMarkets
Never before, or so it seems, have there been so many widely different dynamics in medical technology markets that determine whether a company will be successful, or if successful, to what degree. Science, its application in technology, and its commercialization in healthcare has traditionally been driven by a narrow [...]
New companies in the medical technology industry are pursuing technologies to make existing technologies obsolete, expand existing markets, create new markets and otherwise tap into demand for new solutions in healthcare.
The following are brief technology descriptions for companies newly added to the MedMarket Diligence Medtech Startups Database and/or covered in the Startups coverage in the [...]
(From the September 2007 issue of MedMarkets)
Drawing upon the clinical and technology sectors we have addressed in MedMarkets and the Market and Technology Reports of MedMarket Diligence, we have previously identified a number of areas where we see substantial growth in medical technology markets. In our white paper, High Growth Medical Technologies, we note those [...]
The potential for surgical sealants in cardiovascular applications encompasses the major indications for use in surgical procedures involving peripheral valves, dysfunctional heart valves, congestive heart failure myocardial infarction and coronary heart disease, as shown in the figure at right.
Cardiovascular disease is a major (and growing) public health problem in developed countries, representing a major outlay of healthcare expenditures. [...]